搜索临床试验以:12.5 mg empagliflozin/850 mg 二甲双胍 FDC
总计3141个结果
-
Hanmi Pharmaceutical Company Limited完全的
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.完全的
-
Oregon Health and Science UniversityNational Institutes of Health (NIH)完全的
-
Assistance Publique Hopitaux De Marseille未知
-
Galenicum Health完全的
-
Galenicum Health完全的
-
University Health Network, Toronto招聘中
-
Universitaire Ziekenhuizen KU LeuvenZiekenhuis Netwerk Antwerpen (ZNA)完全的
-
Hunan Province Tumor Hospital招聘中
-
Repros Therapeutics Inc.完全的
-
Pakistan Institute of Medical SciencesRiphah International University完全的
-
Centocor Research & Development, Inc.完全的银屑病美国, 英国, 德国, 加拿大, 奥地利, 法国, 瑞士
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Professor Mikkel ØstergaardMerck Sharp & Dohme LLC完全的
-
National Cheng-Kung University Hospital邀请报名
-
ANRS, Emerging Infectious DiseasesUniversity of Bordeaux; PACCI Program未知新冠肺炎 | 严重急性呼吸系统综合症冠状病毒 2 | COVID-19药物治疗科特迪瓦
-
Uppsala UniversityUppsala University Hospital; Swedish Healthcare Regions; Swedish National Board of Health and... 和其他合作者主动,不招人
-
National Institute of Public Health, SloveniaCommunity Healthcare Center dr. Adolf Drolc Maribor (HCM)邀请报名
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
University of WashingtonBill and Melinda Gates Foundation终止
-
Vertex Pharmaceuticals IncorporatedCystic Fibrosis Foundation完全的
-
GlaxoSmithKline完全的
-
Minerva Neurosciences完全的